ORIGINAL RESEARCH ARTICLES
555 -- High-Dose Hepatitis B Vaccine in Patients Waiting for Lung Transplantation
Mary S. Hayney, Pharm.D., Deborah L. Welter, B.S.N., Ann Marie Reynolds, B.S.N., Mary Francois, B.S.N., and Robert B. Love, M.D.
561 -- Estradiol in Premenstrual Asthma: A Double-Blind, Randomized, Placebo-Controlled, Crossover Study
Mary H. H. Ensom, Pharm.D., FASHP, FCCP, FCSHP, Gina Chong, Danyi Zhou, M.D., Bev Beaudin, R.R.T., Stephen Shalansky, Pharm.D., FCSHP, and Tony R. Bai, M.D.
572 -- Variability in Polyene Content and Cellular Toxicity Among Deoxycholate Amphotericin B Formulations
John D. Cleary, Pharm.D., P. David Rogers, Pharm.D., Ph.D., and Stanley W. Chapman, M.D.
579 -- Aspirin Dosage and Thromboxane Synthesis in Patients with Vascular Disease
Robert G. Hart, M.D., Anne D. Leonard, B.S.N., Robert L. Talbert, Pharm.D., Lesly A. Pearce, M.S., Elaine Cornell, B.S., Edwin Bovill, M.D., and William M. Feinberg, M.D.
585 -- A Gentamicin Pharmacokinetic Population Model and Once-Daily Dosing Algorithm for Neonates
Robert DiCenzo, Pharm.D., Alan Forrest, Pharm.D., Judianne C. Slish, Pharm.D., Carol Cole, B.S., and Ronnie Guillet, M.D., Ph.D.
592 -- Enteral Fluconazole Population Pharmacokinetics in Patients in the Surgical Intensive Care Unit
Prabhu Rajagopalan, Ph.D., Robert K. Pelz, M.D., Ph.D., Pamela A. Lipsett, M.D., Sandra M. Swoboda, M.S.N., Michael G. Rinaldi, Ph.D., and Craig W. Hendrix, M.D.
BRIEF REPORTS
603 -- Assessment of Differences in Antimicrobial Effect Determined with Two In Vitro Pharmacodynamic Models: Impact of Surface Area to Volume Ratio
Roger L. White, Pharm.D., Charles R. Bonapace, Pharm.D., Lawrence V. Friedrich, Pharm.D., Michael J. Rybak, Pharm.D., Diane M. Cappelletty, Pharm.D., Renee-Claude Mercier, Pharm.D., Heather H. Houlihan, Pharm.D., Jeffrey R. Aeschlimann, Pharm.D., and John A. Bosso, Pharm.D.
609 -- Illicit Methylphenidate Use in an Undergraduate Student Sample: Prevalence and Risk Factors
Christian J. Teter, Pharm.D., Sean Esteban McCabe, Ph.D., Carol J. Boyd, Ph.D., and Sally K. Guthrie, Pharm.D.
618 -- The Effect of an Antimicrobial Restriction Program on Pseudomonas aeruginosa Resistance to b-Lactams in a Large Teaching Hospital
Randolph E. Regal, Pharm.D., Daryl D. DePestel, Pharm.D., and Heather L. VandenBussche, Pharm.D.
REVIEW OF THERAPEUTICS
625 -- Treating Dyslipidemic Patients with Lipid-Modifying and Combination Therapies
Chad R. Worz, Pharm.D., and Michael Bottorff, Pharm.D.
MINIREVIEW
638 -- Targeting Bacterial Virulence: The Role of Protein Synthesis Inhibitors in Severe Infections
Insights from the Society of Infectious Diseases Pharmacists
Elizabeth A. Coyle, Pharm.D.
PRACTICE INSIGHTS
643 -- Mississippi Mud No More: Cost-Effectiveness of Pharmacokinetic Dosage Adjustment of Vancomycin to Prevent Nephrotoxicity
William Darko, Pharm.D., Joseph J. Medicis, Pharm.D., Adrienne Smith, Pharm.D., Roy Guharoy, Pharm.D., and David F. Lehmann, M.D., Pharm.D.
651 -- Prescribing Patterns and Outcomes of Enoxaparin for Anticoagulation of Atrial Fibrillation
Minou Khazan, Pharm.D., Ph.D., Sonya Scheuering, Pharm.D., Robert Adamson, Pharm.D., and A. Scott Mathis, Pharm.D.
659 -- Compliance with Clinical Practice Guidelines for Type 2 Diabetes in Rural Patients: Treatment Gaps and Opportunities for Improvement
Ellen L. Toth, M.D., Sumit R. Majumdar, M.D., M.P.H., Lisa M. Guirguis, M.Sc.Pharm., Richard Z. Lewanczuk, M.D., Ph.D., Tzu K. Lee, M.D., and Jeffrey A. Johnson, Ph.D.
666 -- Smoking-Cessation Services in Iowa Community Pharmacies
Mary L. Aquilino, Ph.D., F.N.P., Karen B. Farris, Ph.D., Alan J. Zillich, Pharm.D., and John B. Lowe, Ph.D., FAHPA, FAAHB
CASE REPORTS
674 -- Purple Toes Syndrome Associated with Warfarin Therapy in a Patient with Antiphospholipid Syndrome
David B. Talmadge, B.S., and Alex C. Spyropoulos, M.D., FACP
678 -- Shock-Like Sensations During Venlafaxine Withdrawal
Roy R. Reeves, D.O., Ph.D., James E. Mack, Ph.D., and John J. Beddingfield, M.D.
682 -- Tooth Discoloration After Treatment with Linezolid
Kelly L. Matson, Pharm.D., and Susan E. Miller, Pharm.D.
ALTERNATIVE VIEWPOINTS
686 -- Validity of the General Practice Research Database
Susan S. Jick, D.Sc., James A. Kaye, M.D., Dr.P.H., Catherine Vasilakis-Scaramozza, M.P.H., Luis A. Garc’a Rodríguez, M.D., M.Sc., Ana Ruigómez, M.D., Ph.D., Christoph R. Meier, Ph.D., M.Sc., Raymond G. Schlienger, Ph.D., Corri Black, M.B., and Hershel Jick, M.D.
690 -- Dose Conversion from Epoetin alfa to Darbepoetin alfa for Patients with Chronic Kidney Disease Receiving Hemodialysis
Arnold I. Barnett, Ph.D., and Pierre Y. Crémieux, Ph.D.